Nov 09, 2018
Foot Health for National Diabetes Awareness Month
Oct 29, 2018
Healogics Aims to Raise Awareness of Diabetic Foot Ulcers and Recurrence
Oct 11, 2018
TWO2 Randomized Controlled Trial Chosen as One of the Best Abstracts Presented at the Leading Diabetic Foot Global Conference
Oct 05, 2018
PolarityTE® to Present at the DFCon 2018 Diabetic Foot Global Conference on Clinical Outcomes Associated with SkinTE(TM)
Sep 25, 2018
MiMedx Publishes Positive Results From Clinical Study Of Human Umbilical Cord For Diabetic Foot Ulcers
Sep 12, 2018
Global Diabetic Foot Ulcers Therapeutics Market Report 2018
Aug 24, 2018
MiMedx Announces Statistically Significant Results In New Multicenter Clinical Study Of Healing Of Diabetic Foot Ulcers Using EpiFix®
Jun 26, 2018
Breakthrough Randomized Controlled Trial Demonstrating TWO2 Efficacy in Healing Diabetic Foot Ulcers Unveiled at the American Diabetes Association 78th Scientific Sessions Conference
Jun 21, 2018
Organogenesis Inc. Announces Support of American Diabetes Association
Jun 01, 2018
Wound Care Biologics Market Worth 2.26 Billion USD by 2023
May 09, 2018
IDTechEx Research Report Explores Connected Sensors for the Prevention of Chronic Ulcers
May 01, 2018
Edixomed: Breakthrough Wound Care Technology With Potential to Strike Back Against the Threat of Killer Superbugs
Mar 19, 2018
Proliferative Diabetic Retinopathy Market to Each Roughly US$ 1,000 Million by 2026-end: Transparency Market Research
Feb 14, 2018
Mallinckrodt Enrolls First Patient in Phase 1 Study of ExpressGraft(TM)C9T1 Skin Tissue
Feb 06, 2018
Global Diabetic Footwear Market 2017-2025: Market was Valued at US$ 4,971.25 Mn in 2016, and is Expected to Reach US$ 9,495.01 Mn by 2025
Dec 28, 2017
FDA permits marketing of device to treat diabetic foot ulcers
Nov 28, 2017
Global Diabetic Foot Ulcers Market and Competitive Landscape 2012-2025
Nov 27, 2017
Diabetic Foot Ulcer Therapeutics Pipeline Analysis 2017 - Key Players are Lakewood Amedex, Edixomed & CardioVascular BioTherapeutics Inc
Oct 26, 2017
Proprietary Plasma-Generated Nitric Oxide Technology Being Developed at ADM Tronics for Origin, Inc. Produces Positive Interim Results from Phase IIb Diabetic Foot Ulcer Study
Sep 27, 2017
Lakewood-Amedex Inc. Reports Positive Top-Line Data from Randomized Controlled Phase 1/2a Trial of Nu-3 Antimicrobial in Patients with Infected Diabetic Foot Ulcers